Scilex Holding Stock Today
SCLXW Stock | 0.30 0.08 36.36% |
Performance0 of 100
| Odds Of DistressOver 85
|
Scilex Holding is selling for under 0.3 as of the 3rd of October 2024; that is 36.36% up since the beginning of the trading day. The stock's lowest day price was 0.3. Scilex Holding has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Scilex Holding are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of April 2024 and ending today, the 3rd of October 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 8th of March 2021 | Category Healthcare | Classification Health Care |
Scilex Holding is entity of United States. It is traded as Stock on NASDAQ exchange. More on Scilex Holding
Moving together with Scilex Stock
0.79 | DYAI | Dyadic International | PairCorr |
0.77 | ERNA | Eterna Therapeutics | PairCorr |
0.83 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
Moving against Scilex Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Scilex Stock Highlights
CEO President | Jaisim Shah | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Drug Manufacturers-General, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Scilex Holding can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Scilex Holding's financial leverage. It provides some insight into what part of Scilex Holding's total assets is financed by creditors.
|
Scilex Holding (SCLXW) is traded on NASDAQ Exchange in USA. It is located in 960 San Antonio Road, Palo Alto, CA, United States, 94303 and employs 113 people. Scilex Holding is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry.
Scilex Holding generates negative cash flow from operations
Check Scilex Holding Probability Of Bankruptcy
Scilex Holding Historical Income Statement
Scilex Stock Against Markets
Scilex Holding Corporate Management
Steven JD | Interim Officer | Profile | |
Gigi DeGuzman | Executive Resources | Profile | |
Dmitri MD | Senior Officer | Profile | |
Sumant Rajendran | Executive Marketing | Profile |
Additional Tools for Scilex Stock Analysis
When running Scilex Holding's price analysis, check to measure Scilex Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scilex Holding is operating at the current time. Most of Scilex Holding's value examination focuses on studying past and present price action to predict the probability of Scilex Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scilex Holding's price. Additionally, you may evaluate how the addition of Scilex Holding to your portfolios can decrease your overall portfolio volatility.